We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
Cap. Flow
-$248M
Cap. Flow %
-0.63%
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148

Sector Composition

Rank Sector Weight
1 Technology 11.27%
2 Financials 10.78%
3 Industrials 9.91%
4 Healthcare 9.19%
5 Consumer Staples 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLPH
3626
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$1K ﹤0.01%
42
-408
-91% -$5.28K
CNXM
3627
DELISTED
CNX Midstream Partners LP
CNXM
$1K ﹤0.01%
+39
New +$561
AKRX
3628
DELISTED
Akorn Inc
AKRX
$1K ﹤0.01%
393
BDXA
3629
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
$1K ﹤0.01%
21
-39
-65% -$2.42K
DPLO
3630
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1K ﹤0.01%
+297
New +$1.4K
UCFC
3631
DELISTED
United Community Financial Corp
UCFC
$1K ﹤0.01%
100
FGP
3632
DELISTED
Ferrellgas Partners, L.P.
FGP
$1K ﹤0.01%
5,305
CRC
3633
DELISTED
California Resources Corporation
CRC
$1K ﹤0.01%
141
-45
-24% -$365
UBA
3634
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$1K ﹤0.01%
59
NTP
3635
DELISTED
Nam Tai Property Inc.
NTP
$1K ﹤0.01%
165
BDSI
3636
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1K ﹤0.01%
200
GCVRZ
3637
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$1K ﹤0.01%
1,352
-160
-11% -$123
BHVN
3638
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1K ﹤0.01%
10
ACIC icon
3639
American Coastal Insurance
ACIC
$498M
-160
Closed -$2K
ADPT icon
3640
Adaptive Biotechnologies
ADPT
$3.56B
$0 ﹤0.01%
+1
New +$29
ADTN icon
3641
Adtran
ADTN
$798M
-140
Closed -$2K
AMSC icon
3642
American Superconductor
AMSC
$1.48B
-50
Closed
AOK icon
3643
iShares Core Conservative Allocation ETF
AOK
$803M
-1,155
Closed -$41K
APVO icon
3644
Aptevo Therapeutics
APVO
$5.47M
0
ARKR icon
3645
Ark Restaurants
ARKR
-1,000
Closed -$21K
ASA
3646
ASA Gold and Precious Metals
ASA
$948M
$0 ﹤0.01%
21
ASRT
3647
DELISTED
Assertio
ASRT
$0 ﹤0.01%
4
AVDL
3648
DELISTED
Avadel Pharmaceuticals
AVDL
-364
Closed -$1K
BBGI icon
3649
Beasley Broadcasting Group
BBGI
$37.1M
$0 ﹤0.01%
3
BCRX icon
3650
BioCryst Pharmaceuticals
BCRX
$2.37B
-4,648
Closed -$13K

Similar funds

US Bancorp's Q4 2019 Portfolio in Review

As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
  • US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
  • US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
  • US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
  • US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
  • US Bancorp opened 218 new positions and closed 148 in Q4 2019.
  • US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.

Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.